iZafe Group AB (publ) (IZAFE-B.ST)
SEK 0.25
(-2.34%)
SEK 0.25
(-2.34%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.65 Million SEK | -215.71% |
| 2022 | 2.29 Million SEK | 113.03% |
| 2021 | -17.63 Million SEK | -880.87% |
| 2020 | -1.79 Million SEK | -151.82% |
| 2019 | 3.47 Million SEK | -66.21% |
| 2018 | 10.27 Million SEK | 453.04% |
| 2017 | -2.9 Million SEK | -12.38% |
| 2016 | -2.58 Million SEK | -322.13% |
| 2015 | 1.16 Million SEK | -29.53% |
| 2014 | 1.65 Million SEK | 26.72% |
| 2013 | 1.3 Million SEK | 289.68% |
| 2012 | 334.85 Thousand SEK | 54.06% |
| 2011 | 217.35 Thousand SEK | -65.32% |
| 2010 | 626.73 Thousand SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.55 Million SEK | 158.48% |
| 2024 Q2 | 1.28 Million SEK | -17.11% |
| 2024 Q3 | 3.71 Million SEK | 208.92% |
| 2023 Q2 | -9 Million SEK | 23.9% |
| 2023 Q4 | -2.65 Million SEK | 56.14% |
| 2023 Q3 | -6.06 Million SEK | 32.67% |
| 2023 FY | -2.65 Million SEK | -215.71% |
| 2023 Q1 | -11.83 Million SEK | -614.8% |
| 2022 Q3 | 972 Thousand SEK | 282.71% |
| 2022 FY | 2.29 Million SEK | 113.03% |
| 2022 Q1 | -7.02 Million SEK | 60.18% |
| 2022 Q2 | -532 Thousand SEK | 92.42% |
| 2022 Q4 | 2.29 Million SEK | 136.42% |
| 2021 Q1 | 2.24 Million SEK | 225.03% |
| 2021 FY | -17.63 Million SEK | -880.87% |
| 2021 Q4 | -17.63 Million SEK | -199.15% |
| 2021 Q3 | 17.78 Million SEK | 53.72% |
| 2021 Q2 | 11.57 Million SEK | 414.72% |
| 2020 Q4 | -1.79 Million SEK | 77.51% |
| 2020 Q1 | 8.13 Million SEK | 134.29% |
| 2020 Q2 | 10.19 Million SEK | 25.45% |
| 2020 Q3 | -7.99 Million SEK | -178.37% |
| 2020 FY | -1.79 Million SEK | -151.82% |
| 2019 Q3 | 8.04 Million SEK | -14.36% |
| 2019 FY | 3.47 Million SEK | -66.21% |
| 2019 Q4 | 3.47 Million SEK | -56.85% |
| 2019 Q1 | 5.1 Million SEK | -50.27% |
| 2019 Q2 | 9.38 Million SEK | 83.85% |
| 2018 Q4 | 10.27 Million SEK | 24.98% |
| 2018 FY | 10.27 Million SEK | 453.04% |
| 2018 Q2 | 2.9 Million SEK | 496.51% |
| 2018 Q3 | 8.21 Million SEK | 182.86% |
| 2018 Q1 | 487 Thousand SEK | 116.74% |
| 2017 FY | -2.9 Million SEK | -12.38% |
| 2017 Q1 | -353.57 Thousand SEK | 86.34% |
| 2017 Q2 | -2.01 Million SEK | -470.39% |
| 2017 Q3 | -651.18 Thousand SEK | 67.71% |
| 2017 Q4 | -2.9 Million SEK | -346.72% |
| 2016 Q2 | 873.34 Thousand SEK | 695.79% |
| 2016 Q4 | -2.58 Million SEK | 0.0% |
| 2016 FY | -2.58 Million SEK | -322.13% |
| 2016 Q1 | 109.74 Thousand SEK | -90.58% |
| 2015 Q1 | 1.08 Million SEK | -34.62% |
| 2015 FY | 1.16 Million SEK | -29.53% |
| 2015 Q4 | 1.16 Million SEK | 0.0% |
| 2015 Q3 | 1.16 Million SEK | 2.99% |
| 2015 Q2 | 1.13 Million SEK | 4.66% |
| 2014 Q3 | 1.58 Million SEK | 1.66% |
| 2014 Q1 | 1.3 Million SEK | -0.24% |
| 2014 Q2 | 1.55 Million SEK | 19.45% |
| 2014 FY | 1.65 Million SEK | 26.72% |
| 2014 Q4 | 1.65 Million SEK | 4.61% |
| 2013 Q1 | 695.6 Thousand SEK | 107.74% |
| 2013 Q4 | 1.3 Million SEK | 11.45% |
| 2013 Q3 | 1.17 Million SEK | 22.82% |
| 2013 Q2 | 953.24 Thousand SEK | 37.04% |
| 2013 FY | 1.3 Million SEK | 289.68% |
| 2012 FY | 334.85 Thousand SEK | 54.06% |
| 2012 Q3 | -91.3 Thousand SEK | 0.0% |
| 2012 Q4 | 334.85 Thousand SEK | 466.76% |
| 2011 FY | 217.35 Thousand SEK | -65.32% |
| 2010 FY | 626.73 Thousand SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.01 Billion SEK | 100.053% |
| Biotage AB (publ) | -444 Million SEK | 99.401% |
| Bonesupport Holding AB (publ) | -149.86 Million SEK | 98.226% |
| Doxa AB (publ) | -102.2 Million SEK | 97.398% |
| Elekta AB (publ) | 4.46 Billion SEK | 100.059% |
| Ortivus AB (publ) | 4.19 Million SEK | 163.43% |
| Ortivus AB (publ) | 4.19 Million SEK | 163.43% |
| Q-linea AB (publ) | -61.33 Million SEK | 95.664% |
| S2Medical AB (publ) | -1.51 Million SEK | -75.277% |
| Synsam AB (publ) | 2.67 Billion SEK | 100.099% |